Singapore-based Precious Medical Group has announced the launch of the Tunku Laksamana Johor Cancer Centre and Hospital in Johor Bahru, a significant $106m (RM500m) investment aimed at enhancing cancer care in Malaysia. The facility, set to open on 5 December 2025, will feature state-of-the-art diagnostic and treatment technologies, including a PET-CT and radiotherapy centre.
The centre will house Malaysia’s first cyclotron outside the Klang Valley, enabling local production of medical radioisotopes for cancer imaging and therapy. This advancement is expected to improve early detection and treatment availability whilst reducing reliance on distant supply chains. The project is strategically located at Larkin Sentral within the Johor–Singapore Special Economic Zone (JS-SEZ), facilitating cross-border medical collaboration and talent mobility.
The development is projected to create approximately 1,000 direct and indirect jobs, contributing to the economic goals of the JS-SEZ. Following the cancer centre’s inauguration, Precious Medical Group plans to develop a 200-bed hospital on the same site, offering comprehensive inpatient oncology and integrated support services.
Named after the late Tunku Abdul Jalil, the fourth child of His Majesty Sultan Ibrahim of Johor, the hospital aims to strengthen Malaysia’s healthcare system, which already attracts over 1.5 million medical tourists annually. This initiative is poised to bolster the international reputation of Malaysia’s healthcare sector, enhancing its capacity and resilience.
